GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 main protease (mpro) Q192T mutant in complex with inhibitor GC376

Analyse Crystal structure of SARS-cov-2 main protease (mpro) Q192T mutant in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8DGB
Type
protein
Length
608 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase NSP5
EC
3.4.22.69
UniProt
P0DTD1
Ligands
B1S
Pockets
4 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B3C-like proteinase NSP5 (EC 3.4.22.69)protein30426% helix, 29% strandP0DTD1

Ligands and binding sites

  • B1S · (1R,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19560.770.7985empty
25620.620.7472empty
32110.560.7929B1S
41810.520.7830B1S

Interfaces

1 interface between chains.

  • A–B · 1608 Ų buried · 41 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 8DGB · Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Q192T Mutant in Complex with… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.